Bridge Creek Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.01M | Buy |
4,965
+866
| +21% | +$351K | 0.59% | 64 |
|
|
2025
Q1 | $2.04M | Buy |
4,099
+33
| +0.8% | +$16.4K | 0.64% | 62 |
|
|
2024
Q4 | $2.12M | Buy |
4,066
+15
| +0.4% | +$7.8K | 0.65% | 62 |
|
|
2024
Q3 | $2.51M | Hold |
4,051
| – | – | 0.76% | 59 |
|
|
2024
Q2 | $2.24M | Hold |
4,051
| – | – | 0.72% | 63 |
|
|
2024
Q1 | $2.35M | Buy |
4,051
+15
| +0.4% | +$8.72K | 0.75% | 62 |
|
|
2023
Q4 | $2.14M | Buy |
4,036
+152
| +4% | +$80.7K | 0.74% | 59 |
|
|
2023
Q3 | $1.97M | Buy |
3,884
+15
| +0.4% | +$7.59K | 0.75% | 60 |
|
|
2023
Q2 | $2.02M | Hold |
3,869
| – | – | 0.72% | 60 |
|
|
2023
Q1 | $2.23M | Sell |
3,869
-15
| -0.4% | -$8.65K | 0.84% | 54 |
|
|
2022
Q4 | $2.14M | Buy |
3,884
+270
| +7% | +$149K | 0.84% | 55 |
|
|
2022
Q3 | $1.83M | Buy |
3,614
+239
| +7% | +$121K | 0.79% | 53 |
|
|
2022
Q2 | $1.83M | Buy |
3,375
+383
| +13% | +$208K | 0.75% | 56 |
|
|
2022
Q1 | $1.77M | Buy |
2,992
+1,197
| +67% | +$707K | 0.59% | 61 |
|
|
2021
Q4 | $1.2M | Sell |
1,795
-55
| -3% | -$36.7K | 0.4% | 65 |
|
|
2021
Q3 | $1.06M | Buy |
1,850
+25
| +1% | +$14.3K | 0.39% | 68 |
|
|
2021
Q2 | $921K | Buy |
1,825
+1,155
| +172% | +$583K | 0.34% | 71 |
|
|
2021
Q1 | $306K | Buy |
670
+235
| +54% | +$107K | 0.12% | 94 |
|
|
2020
Q4 | $203K | Buy |
+435
| New | +$203K | 0.08% | 91 |
|